Abstract
Statement of Retraction: Clinical practice of epidermal growth factor receptor-tyrosine kinase inhibitor targeted drugs combined with gadolinium oxide nanoparticles in the treatment of non-small cell lung cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have